SI-BONE grows Q3 revenue 14.5% to $55.7 million and reaffirms 2026 sales guide
GlobeNewswire · · AI-summarised by FinFlash
SI-BONE reported third-quarter worldwide revenue of $55.7 million, up 14.5% from $48.7 million, helped by US procedure volumes rising about 19.5%. Gross margin slipped to 79.3% from 79.8%, and the net loss narrowed to $3.6 million, or $0.08 a share. The medical device maker kept its 2026 revenue forecast at $231 million to $233 million and lowered expected operating expense growth to about 10.5% from 12%.
So What?
Lower expense growth points to better operating leverage for the small-cap spine implant maker. New inpatient payment codes for complex spinal fusion are the next driver to monitor.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.